BackOno Pharmaceutical , Ltd. Overview

Ono Pharmaceutical , Ltd. Goodwill

Track Ono Pharmaceutical , Ltd.'s goodwill ($23B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$22.84B
↑ 11.32% YoYΔ $2.32B vs prior year quarter

Peer trimmed avg / median

Loading

Ono Pharmaceutical , Ltd. Goodwill History

Loading

Ono Pharmaceutical , Ltd. vs. peers: Goodwill Comparison

Loading

Ono Pharmaceutical , Ltd. Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Ono Pharmaceutical , Ltd. (OPHLF) FAQ

Ono Pharmaceutical , Ltd. (OPHLF) currently reports a goodwill of $23B as of June 2026. That compares with $21B in the prior-year period — up 11.3% year over year. Use the charts on this page to explore Ono Pharmaceutical , Ltd.'s goodwill history and peer comparisons.

Ono Pharmaceutical , Ltd.'s goodwill increased from $21B to $23B — a 11.3% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Ono Pharmaceutical , Ltd. reported $23B in goodwill as of June 2026. That compares with $21B in the prior-year period — up 11.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current goodwill of $23B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Ono Pharmaceutical , Ltd., and consider following OPHLF for alerts when major investors trade the stock.